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Hybrid nanocomposite as a 
chest wall graft with improved 
integration by adipose-derived 
stem cells
Johanna Buschmann  1, Yoshito Yamada2, Konstantin schulz-schönhagen  3, 
samuel C. Hess3, Wendelin J. stark3, Christine opelz2, Gabriella Meier Bürgisser1, 
Walter Weder2 & Wolfgang Jungraithmayr2,4
surgery of the chest wall is potentially required to cover large defects after  removal of malignant 
tumours. Usually, inert and non-degradable Gore-tex serves to replace the missing tissue. However, 
novel biodegradable materials combined with stem cells are available that stimulate the healing. 
Based on poly-lactic-co-glycolic acid and amorphous calcium phosphate nanoparticles (pLGA/aCap) 
and pure pLGA, a dual layer biodegradable hybrid nanocomposite was generated. Mouse adipose-
derived stem cells were cultered on electrospun disks (ASCs of C57BL/6), and biomechanical tests 
were performed. The cell-seeded scaffolds were engrafted in C57BL/LY5.1 mice to serve as a chest 
wall substitute. Cell invasion into the bi-layered material, extent of CD45+ cells, inflammatory 
response, neo-vascularization and ECM composition were determined at 1 and 2 months post-surgery, 
respectively. The bi-layered hybrid nanocomposite was stable after a 2-week in vitro culture, in contrast 
to pLGA/aCap without a pLGA layer. there was a complete biointegration and good vascularization 
in vivo. The presence of ASCs attracted more CD45+ cells (hematopoietic origin) compared to cell-free 
scaffolds. Inflammatory reaction was similar for both groups (±ASCs) at 8 weeks. A bi-layered hybrid 
nanocomposite fabricated of electrospun pLGA/aCap and a reinforcing layer of pristine pLGA is an ideal 
scaffold for chest wall reconstruction. It is stable and allows a proper host tissue integration. If ASCs are 
seeded, they attract more CD45+ cells, supporting the regeneration process.
Many chest wall discontinuities follow from the removal of aggressive tumors1,2, needing adequate covering and 
chest wall reconstruction3. The repaired chest wall should be stable and well integrated into the surrounding tis-
sue. On the one hand, there are different grafts in use: Myocutaneous4, muscle5,6, pedicled or free myocutaneous 
or osseomyocutaneous7 as well as fasciocutaneous and omental or breast flaps8,9. On the other hand, biomaterials 
offer a viable option – either synthetic10,11 or natural like cellulose12, among others13,14.
Synthetic materials, such as prolene, polypropylene meshes or Gore-Tex, are utilized for chest wall recon-
struction in daily clinical practice15, also in combination with perforator flaps16 or small intestinal submucosa, a 
natural product that is made cell-free before application14,17. Biointegration of chest wall grafts may be improved 
by cellular therapy, for example by seeding stem cells onto the material. This approach has been delineated for 
adipose-derived stem cells (ASCs) seeded on artificial hernia18, sternal reconstruction19 and onto a POC-PLA 
patch for chest wall repair20. Moreover, the application of bone-marrow derived stem cells for sternum recon-
struction21 as well as osteogenic induced stem cells in chest wall replacement22 have been shown to be superior 
than cell-free approaches.
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As a goal to treat full-thickness chest wall defects effectively, the implanted material needs to be firm and 
surgeon-friendly, fluid- and air-tight as well as biocompatible. During healing, it should degrade without any 
toxic side products. In addition, fast and full integration into the adjacent tissue should be warranted. At best, 
the graft evokes cell homing of progenitor cells with a regenerative potential. Biomimetic materials23 imitating 
non-skeletal and skeletal parts of the critical size wound, would enable a rapid and easy involvement of the mate-
rial into the surrounding tissues. Additionally, adult stem cells might aid the processes of integration, cell homing 
and/or immunomodulation24,25.
Here, we used an adjustable, biodegradable and biocompatible electrospun mesh, composed of two layers, 
one fabricated from poly(lactic-co-glycolide)/amorphous calcium phosphate (PLGA/aCaP) and the other from 
pure PLGA, respectively. This hybrid scaffold was intended to be more stable after cell-seeding compared to the 
mono-layered nanocomposite PLGA/aCaP that has been used as a chest wall graft previously26. Our group has 
shown before that PLGA/aCaP holds great promise in terms of thoracic wall reconstruction27. Additionally, the 
presence of murine ASCs on PLGA/aCaP has been reported earlier to significantly reduce the inflammatory 
reaction26.
ASCs are easily harvested, prevailing in abundance28 and adequate proliferation and migration into electro-
spun meshes composed of PLGA/aCaP has been shown29,30. Hence, they represent an ideal stem cell source to 
seed a chest wall construct.
In order to study the effects of murine C57BL/6 ASCs seeded on a stable, electrospun hybrid material with two 
layers, to close chest wall defects, PLGA/aCaP scaffolds with ASCs were used as chest wall grafts in a thoracic wall 
defect C57BL/LY5.1 murine model (endpoints 1 and 2 months). C57BL/LY5.1 mice were used to determine the 
extent of CD45+ cell attraction to the graft. Tensile testing of the novel hybrid scaffold and the two components 
alone was performed in dry state and after a 2-week incubation in culture medium. Cell densities were assessed 
(entire cell density, density of endothelial cells, as well as macrophages, lymphocytes and foreign body giant cells); 
and ECM composition was analyzed by immunohistochemical staining and subsequent histomorphometry.
The hypotheses were that
 (i) the cell-seeded hybrid scaffold is more stable than a cell-seeded pure PLGA/aCaP scaffold and thus offers 
easier handling during implantation,
 (ii) ASCs modulate the inflammatory response towards the hybrid scaffold (control cell-free hybrid scaffold),
 (iii) ASC-seeded hybrid scaffolds promote the healing process by attraction of CD45+ cells and
 (iv) ASCs positively influence neo-angiogenesis and ECM remodeling.
Materials and Methods
Scaffolds. PLGA (85% lactic acid and 15% glycolic acid, clinically approved) was purchased from Boehringer 
Ingelheim am Rhein, Germany. The nanoparticles having a Ca:P ratio of 1.5, were received via flame spray pyrol-
ysis as reported by Loher et al.31. To combine PLGA and the aCaP nanoparticles, the identical protocol was used 
as reported previously27. Hybrid scaffolds were fabricated by electrospinning of two layers; with a 500 µm thick 
layer of PLGA/aCaP and a 30 µm thick layer of PLGA. The hybrid scaffolds were investigated with scanning elec-
tron microscopy (SEM, FEI, Nova NanoSEM 450) (Fig. 1). Transmission electron microscopy (TEM, FEI, Philips 
CM 12) was used to obtain information regarding particle morphology and to determine the particles’ primary 
diameter (≈22 nm)27,29.
Hybrid scaffold disks with a diameter of 1 cm and and a hight of ≈ 530 µm were prepared. For sterilization, the 
scaffolds were immersed into a phosphate buffer solution with 200 µg/mL gentamycine (Biowest, Teco Medical, 
Sissach, Switzerland) and 2.5 µg/mL amphotericine (Biowest, Teco Medical, Sissach, Switzerland) overnight26,27,29.
Adipose-derived stem cells: source and properties. Three specific pathogen-free, male 24 
C57BL/6 mice (Harlan, Netherlands) were used to harvest fat tissue samples from abdominal lipectomies26. 
Adipose-derived stem cell extraction was performed according to Zuk et al.32. Isolated cells were merged and 
Figure 1. Scaffold characterization. SEM images of the hybrid scaffold at two different magnifications. In (A) 
the fibres of PLGA/aCaP are visible at a 305× magnification; in (B) also the thin layer of pure PLGA fibres on 
top of the PLGA/aCaP fibers is visible (198× magnification).
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cultured in DMEM medium (Biowest, Teco Medical, Sissach, Switzerland), complemented by 10% of FBS 
(Biowest, Teco Medical, Sissach, Switzerland) and 50 μg mL−1 gentamycine. Passaging of ASCs was performed 
with 2.5% trypsin/0.23 mM EDTA. Cell were counted with the Neubauer chamber (n = 4)26.
Characterization of murine ASCs (extracted from fat of C57BL/6 mice) was based on quantitative RT-PCR; 
expression levels of CD34, CD44, CD105, ALP, Oct 4, Sox 2, Nanog, Pecam-1, VEGFR1 and VEGFR2 were 
assessed as described previously26.
Scaffold seeding. The first seeding was realized by carefully placing 106ASCs from P4 to P7 in 100 µL cell 
culture medium on top of each hybrid scaffold. Subsequently, all seeded scaffolds were cultivated in 6-well plates 
using 7 mL DMEM medium with 10% of FBS and 50 µg mL−1 gentamycine26.The second seeding was performed 
after 24 h, when the scaffolds were turned and seeded with 106 ASCs. Without further turning, the scaffolds were 
cultivated in a humidified atmosphere of 95% air and 5% CO2 at 37 °C for two weeks26. Medium was changed 
every 3 or 4 days. These samples were either fixated overnight by 4% formalin in PBS (Kantonsapotheke Zurich, 
Switzerland) and then stained (time point 0) or they were used as a chest wall graft in vivo. For each condition, 
there were triplicates (n = 3).
Animals. Specific pathogen-free, male 24 C57BL/LY5.1) mice (Harlan, Netherlands), weighing 25 g to 29 g, 
were used. Mice received adequate care in accordance with the Guide for the Use of Laboratory Animals (National 
Institutes of Health Publication 85-23, revised 1996; Bethesda, MD)26. The local animal committee approved the 
study protocol (Licence of Zürcher Veterinäramt No. ZH002/16).
treatment groups. A total of 12 mice were used for the chest wall replacement experiments. Six mice were 
sacrificed at 4 and six mice at 8 weeks post-operation, respectively. Half of the mice received a cell-free hybrid 
scaffold, the other half a cell-seeded construct.
surgical procedures. All steps of the aforementioned procedure were performed under sterile conditions, 
using an operating microscope (Wild, Heerbrugg, Switzerland) with 30–40 × magnification27. Animals were 
anesthetized and treated as reported before27.
During chest wall reconstruction, animals were placed on a small section of rolled gauze (serving as a counter-
fort to enhance widening of the intercostal space) on their right side. The lateral left hemi-thorax of the animals 
was shaved and disinfected27. The thoracic wall was freed by ubtle preparation of the subcutaneous and muscle 
tissue. A piece of 4 mm × 4 mm from the thoracic wall was excised and either a cell-free or a cell-seeded hybrid 
scaffold was introduced into this gap by running sutures (5-0 prolene, Ethicon, Livingston, Scotland)27. No ana-
tomical and physiological change developed because the scaffold was carefully sutured in line with the thoracic 
wall.
Histology. After extraction, the graft specimens were fixated in formalin (Kantonsapotheke, Zürich, 
Switzerland). They were subsequently dehydrated and paraffin-embedded. The sections were 5 µm thick. H&E 
and Hemalaun-Sudan stainings were performed according to commonly established procedures after depa-
raffinizing with xylene (Fluka, Switzerland) and rehydrating the sections (descending gradient of ethanol (Fluka, 
Switzerland)33.
Immunohistochemistry. Immunohistochemistry (IHC) was performed on paraffin sections of forma-
lin fixated tissues, with a Ventana Benchmark automated staining system (Ventana Medical Systems, Tucson, 
Arizona). For antigen retrieval, slides were heated with cell conditioner 1 (standard procedure). Endogenous 
biotin was blocked with the appropriate kit26. Primary monoclonal rat antibody against F4/80 (BMA Biomedicals 
AG, clone BM8, dilution 1:200), rabbit antibody against CD3 (DAKO, clone SP7, dilution 1:300), CD31 (Abcam 
Limited, polyclonal, dilution 1:50), α-smooth muscle actin (DAKO, dilution 1:2), collagen I (Abcam Limited, 
dilution 1:100), CD45 (BD Pharmingen, dilution 1:50) and fibronectin (Millipore, dilution 1:200) were applied 
and revealed with the iVIEW DAB detection kit, yielding a brown reaction product. The signal was enhanced 
with the Ventana amplification kit. Prior to glass coverslipping, the slides were counterstained with hematoxylin 
(HT)26.
Immunohistological analysis was performed with ImageJ 1.51t16. Details for the different IHC stainings: 
alpha-SMA, collagen I, fibronectin and F4/80 relative intensities were assessed by defining the scaffold area in 
the tissue sections. Subsequently the pixles stained with Hematoxylin and DAB were detected using QuPath v 
0.1.2. The percentage of DAB stained pixels of the total stained area (Hematoxylin & DAB) were plotted. Always 
two tissue section per mice were averaged. Vascularization was counted in five zones. The images were color 
de-convoluted and converted to a binary image. The vessels were detected with the particle count function of 
ImageJ. Lymphocytes were counted in five zones. The lymphocytes were detected with the particle count function 
of ImageJ. CD45 intensity was scored in 60 fields of view (FOV) for semi-quantitative assessment, while CD45+ 
cell density was determined in fifteen FOV.
Cell counting in different local zones. Six zones (z1–z6) were defined starting from the outer periphery: 
z1 = 0–25 µm, z2 = 25–50 µm, z3 = 50–75 µm, z4 = 75–100 µm, z5 = 100–150 µm, z6 = 150–350 µm with fifteen 
FOV for each zone, time point and side (towards skin and lung)27.
tensile testing. Bulk mechanical properties of the pure PLGA, pure PLGA/aCaP and the hybrid meshes 
were determined (n = 5). Stress-strain curves of the scaffolds were recorded and ultimate stress (failure stress 
[MPa]) was evaluated. The tests were performed at time point 0 in dry state and after 2 weeks of incubation in 
DMEM culture medium in wet state.
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statistical analysis. All data were analyzed with StatView 5.0.1 software. One-way statistical analysis of 
variance (ANOVA) was conducted to test the significance of differences between different groups, time points 
and local zones. Pairwise comparison probabilities (p) were calculated using the Fisher’s PLSD post hoc test to 
test for differences between the groups27. P values < 0.05 were considered significant and marked by (*), p < 0.01 
(**) and p < 0.001 (***). Values were expressed as means ± standard deviations.
Results
Tensile strength of hybrid scaffold. One of the main reasons to further develop our chest wall graft 
material used previously cell-free27 and ASC-seeded26 was the fact that two weeks of cell seeding and cultivation 
in vitro prior to implantation changed the mechanical stability drastically resulting in weak cell-seeded grafts. 
Hence, pure PLGA, pure PLGA/aCaP and newly developed hybrid meshes (PLGA-aCaP/PLGA) were used for 
tensile testing. While pure PLGA had the highest failure stress, followed by the hybrid mesh, both being signifi-
cantly higher than pure PLGA/aCaP mesh, a 2-week incubation in DMEM lowered the maximum strength for all 
three scaffold materials; in case of PLGA and hybrid scaffold only to a minor extent. For PLGA/aCaP, however, 
the ultimate strength was significantly reduced to zero (Fig. 2).
Scaffold integration. The hybrid scaffold was very well integrated into the surrounding tissue, for both, 
cell-seeded and cell-free scaffolds and from the skin as well as from the lung side, respectively. The thin reinforc-
ing PLGA layer had started to degrade at 4 weeks and even more so at 8 weeks post-operation, leaving behind 
a layer broken up into discrete pieces of varying size (Fig. 3). As for the PLGA/aCaP thicker layer of the hybrid 
scaffold, cells had completely invaded all pores between the electrospun fibers.
total cell density. The number of all cells per area is given for different periods post-operation and local 
sectors in the scaffolds with ASCs compared to scaffolds without ASCs (Fig. 4). The number of all cells per area at 
8 weeks post-surgery was similar for scaffolds with and without ASCs, respectively, and they were homogenously 
distributed over all layers.
Cells of hematopoietic origin: CD45+. CD45 staining revealed an increase in CD45+ cells at 8 weeks 
compared to 4 weeks for the ASC-seeded scaffolds, while it was not significantly increased in the hybrid scaffold 
without ASCs (Fig. 5). Moreover, the semi-quantitatively determined CD45 intensity was significantly higher at 8 
weeks for cell-seeded materials as compared to scaffolds without cells at 4 weeks. Three cell types, CD45+ stained, 
were analyzed quantitatively: (i) roundish lymphocytes with a thin brown membrane and a blue core were found 
to be significantly increased at 8 weeks in the ASC-seeded samples, confirming findings by a more detailed, zone- 
and side-specific analysis of lymphocytes by CD3 staining (see below); (ii) spindle-shaped cells CD45 cells with a 
blue core and (iii) spindle-shaped CD45+ cells without blue core.
Fibrosis. α-SMA staining revealed no statistically significant differences, neither between the ASC-seeded and 
the cell-free scaffolds nor as a function of time (Fig. 6).
extracellular matrix. Extracellular matrix composition was analyzed by collagen I und fibronectin staining 
(Fig. 6). For collagen I, a significant increase between 1 and 2 months was found for the cell-free scaffolds, but not 
for the ASC-seeded ones. As for fibronectin, no significant differences were observed; neither for the impact of 
cell seeding nor time point post-operation.
Figure 2. Mechanical properties. Ultimate tensile stress of dry electrospun (incubation time = 0) and of wet 
scaffolds after a 2-week incubation in DMEM culture medium.
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Inflammatory reaction. The fraction of F4/80+ macrophages of the total cell number is shown in SI Fig. 1. 
Although there was no significant increase over time, for both, the cell-free and the cell-seeded scaffolds, respec-
tively, scaffolds with ASCs exhibited higher percentages of macrophages compared to cell-free ones.
CD3+ lymphocytes were present under both conditions; in chest wall grafts with and without cells (Fig. 7). 
While ASC-seeded scaffolds were infiltrated by significantly more lymphocytes at 4 weeks and for both sides 
(from the skin side and the lung side, respectively), this effect completely vanished at 8 weeks for the lung side, 
and was only observed for two distinct zones inside the material on the skin side.
Neo-angiogenesis. In Fig. 8, the number of CD31+ stained cells were assessed for the defined zones on the 
skin as well as on the lung side for both time points and ±ASCs. While there were no significant differences on 
the skin side, the analysis of the lung side revealed significantly moreCD31+ cells for the grafts without cells at 8 
weeks. Only in z1 and at 4 weeks, it was the opposite – with significantly more CD31+ cells for ASC-seeded grafts.
Discussion
Previously, our research team has demonstrated that cells infiltrate better into a porous electrospun PLGA/
aCaP nanocomposite (without seeded cells) used as a chest wall graft in mice compared to the non-porous inert 
Gore-Tex material that is currently used as a gold standard27. In addition, the new vasculature was uniform 
throughout the PLGA/aCaP material, while almost no vessels infiltrated into Gore-Tex27. Therefore, electrospun 
PLGA/aCaP nanocomposite was considered a convenient novel scaffold for thoracic wall reconstruction.
In a subsequent study, PLGA/aCaP was seeded with ASCs, leading to a reduced inflammatory reaction 
towards the material as assessed by F4/80+ macrophages and CD3+ lymphocytes26. The major drawback, however, 
Figure 3. Scaffold degradation in vivo. Hemalaun Sudan stained section of ASC-seeded scaffolds 4 and 8 weeks 
post-operation, respectively. Black arrows depict degrading PLGA areas and white arrows PLGA/aCaP. Note, 
PLGA builds up discrete pieces (larger at 4 weeks, smaller at 8 weeks), while PLGA/aCaP is completely and 
homogenously invaded by cells.
Figure 4. Cell distribution. Entire cell density as a function of period post-surgery and local sector for cell-free 
hybrid scaffolds and for ASC-seeded grafts, respectively, and from the skin side (A) and the lung side (B). No 
statistically significant differences in total cell density were found between scaffolds with and without ASCs.
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was the insufficient stability of PLGA/aCaP after cell seeding and a 2-week in vitro cultivation, which was resolved 
at that time by adding a cell-free nanocomposite layer that had not experienced contact with cell culture medium 
before26.
To overcome the problem of graft instability, we developed a novel, more stable hybrid scaffold for chest wall 
repair, consisting of electrospun PLGA/aCaP and pure PLGA (Fig. 1), the latter realized as a thin reinforcing 
layer. Upon cell seeding, this hybrid scaffold beholds its initial stability (Fig. 2) and is easily handled during 
implantation, especially during suturing.
In contrast to ASC-seeded pure PLGA/aCaP nanocomposite26, however, we found a significantly increased 
CD3+ lymphocyte cell density 4 weeks post-operation (Fig. 8). Such increased lymphocyte accumulation stand 
in accordance with Gong and co-workers, who determined more CD3+ cells in human ASC-treated group com-
pared to control (cell-free)34. We speculate that PLGA releases hydrogen cations resulting in a local pH drop35, 
which might be affecting the sensitive ASCs, resulting in an in situ lymphocyte accumulation. This effect vanished 
Figure 5. Cells of hematopoietic origin. Semi-quantitative analysis of CD45 positive staining. Representative 
examples for each score and data for in vivo outcome (top, A). Histological section to exemplify cell types with 
different brown intensities within the cells (middle left, B); Key: white arrow = CD45+ lymphocytes; bold 
black arrow = spindle-shaped cells CD45+ cells with blue core; and thin black arrow = totally brown stained 
CD45+ cells. Analysis of CD45+ lymphocytes (middle right, C), spindle-shaped cells CD45+ cells with blue core 
(lower left,D) and spindle-shaped CD45+ cells without blue core (lower right, E). Key: wo = without; w = with; 
4w = four weeks; 8w = 8 weeks.
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at 8 weeks post-operation, confirming an only transiently increased inflammatory reaction in the ASC-seeded 
hybrid scaffolds.
In accordance to our previous findings26, the ASC-seeded hybrid nanocomposite showed lower numbers of 
CD31+ cells than the cell-free scaffold, implying fewer and/or smaller vessels in the cell-seeded graft (Fig. 8): 
ASC seeding increases cell densities in the pores of the electrospun scaffolds, which might hinder new vessel 
ingrowth by steric hindrance. Nevertheless, compared to totally avascular Gore-Tex27, both, the cell-free and the 
ASC-seeded novel hybrid scaffolds were well and homogenously vascularized.
The patient group that profits most from that kind of chest wall reconstruction is that with a malignant chest 
wall tumour, either arising from the chest wall itself or from a lung cancer that is infiltrating the chest wall. But 
how to choose an appropriate material to close such chest wall defects? The heterogeneous structure of the chest 
wall, including soft tissue, cartilage and bone, demands for materials allowing the reconstruction of tissues with 
a wide range of stiffness, topography and composition. A viable option is to use vascularized composite allo-
grafts36, but also the application of cell-free grafts derived from different tissues is suitable. Due to its integra-
tive and flexible properties, dermis had been successfully applied to close thoracic wall defects. Among others, 
Permacol, a decellularized porcine dermal collagen matrix properly covered thoracic wall defects in children 
undergoing resection of malignancies37 - without any adverse reactions. In addition, a good material for thoracic 
wall replacement should be stable and needs to seal the pleura, thus should be well covered with connective tissue. 
Additionally, it should be flexible enough to be properly fixed at the edges of the defect. Finally, it should protect 
the viscera and prevent infection15.
Biological grafts serve these claims, such as muscle6, myocutaneous flaps or fascias38–41. In addition, tradi-
tional hernia repair pieces have proven to successfully close the chest wall after tumour resection (chondro-
sarcoma) as reported in a case study42. In order to strengthen the hernia, a synthetic Dacron patch (made of 
Figure 6. Fibrosis. α-SMA staining in representative histological sections at two time points (A–D), 
semi-quantitative analysis of α-SMA intensity (E) and collagen I and fibronectin intensities in 
immunohistochemically stained sections (F). Key: 4w = four weeks; 8w = 8 weeks, DAB = DAB staining, 
HT = hematoxylin.
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polyethyleneterephtalate (PET) fibres) was fixed on top, exemplifying that biological and synthetic materials go 
hand in hand in the operation room42.
Other synthetic polymers like poly-lactic-acid (PLA) are appropriate materials15, and metal plates of titanium 
coated with acellular collagen matrix have rebuilt the thoracic wall integrity with a satisfactory outcome43. Chest 
repair by means of prosthetic metal materials, such as steel or titanium, is also used: Matrix Rib titanium plates 
were successfully applied in patients suffering from sternocostal non-union, pseudoarthrosis or dislocated ribs44. 
Recently, 3D printing approaches have been investigated and may deliver next generations materials for chest 
wall reconstruction45–47. Reviews that present suitable graft materials, the choice of which may be driven by cost 
effectiveness48, and the surgeon’s preference49,50. There is no consensus which graft material is the best one.
Electrospun PLGA/aCaP was chosen as this material is fabricated from a ceramic (amorphous calcium 
phosphate nanoparticles) and an organic phase (PLGA) – enabling bio-mimesis of different tissues that are part 
of the thoracic wall; bone, cartilage and connective tissue. The inorganic nanoparticles are transformed into 
hydroxyapatite (HAp), which in turn stabilizes the graft. An important characteristic of (the in situ generated) 
HAp is its tight binding to collagen in the soft tissue, based on covalent bonds between hydroxyl groups and 
stromal collagen. Furthermore, in contact with bone, HAp binds to collagen fibrils, forming a direct bond to 
bone51–53. Thus, this bioactive nanocomposite allows both, a stable integration in soft tissue as well as in hard 
tissue like sternum.
The highly porous structure of PLGA/aCaP enables also an easy vascularization27. Successful previous studies 
have reported that PLGA/aCaP had been applied as a bone void filler during calvarial repair in a rabbit model 
showing sufficient and homogenous vascularization54 and in long bone critical size defects in sheep55.
Why might ASCs improve the nanocomposites functionality? As multipotent cells, ASCs can differentiate 
towards various cell types, such as bone cells, cells in cartilage and vessels28. They are therefore offering versatile 
functions at different places of the chest wall graft. Furthermore, ASCs regulate the immune system56,57, and their 
anti-inflammatory action58 can be of advantage.
Here, ASCs attracted more cells of hematopoietic origin to the chest wall defect compared to cell-free grafts: 
there were more CD45+ lymphocytes, but also spindle-shaped CD45+ cells. This implies a better remodelling via 
blood-supplied cells compared to cell-free grafts. It is especially noteworthy to mention, because ASC-seeded 
grafts exhibited lower CD31+ cell densities, in other words, less vessels that allowed the recruitment of CD45+ 
cells to the repair site. We were not able to further identify the CD45+ spindle-shaped cells, which had either a 
blue core (not CD45+) or a throughout brown colour (all CD45+). It might be speculated that these cells with an 
Figure 7. Lymphocytes. Typical CD3 stained histological sections and densities of lymphocytes at two different 
time points (A–D) stained positive for CD3 in different zones from skin side (E) and from lung side (F).
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obviously a hematopoietic origin (from Ly5.1 CD45+ mice), were de-differentiated monocytes or epithelial pre-
cursor cells. The ASC-seeded grafts must have attracted these kind of cells to the repair site by paracrine function, 
because ASCs do not remain for 8 weeks at the site of action, but are usually washed out earlier. It was reported 
that ASC-seeded polysiloxane/collagen scaffolds did not have any ASCs left on the scaffold after a 30-day period59.
Therapeutic approaches based on ASCs can affect lung inflammation. COPD, the chronic obstructive 
pulmonary disease, was induced in a pig model with smoke from cigarettes. ASC therapy decreased tracheal 
hyper-responsiveness and lung inflammation58. The paracrine effect of ASCs observed as suppressed allergic 
airway inflammation has been attributed to PGE2 (prostaglandin E2) and TGF-β (transforming growth factor 
beta), both secreted by ASCs60. Furthermore, ASCs not only decreased inflammatory response in white adipose 
tissue of a mouse model, but also led to a switch of M1 to M2 macrophages by paracrine function61,62. It is there-
fore not surprising that ASCs that were applied in an inflammation model of rats suppressed pro- and enhanced 
anti-inflammatory cytokines63.
Although all these examples show a positive effect in terms of restricting inflammatory response, we found a 
slightly higher inflammatory reaction towards our novel hybrid material, as macrophages were increased in the 
ASC-treated graft at 8 weeks (Fig. 7). It has to be emphasized, however, that F4/80 staining to assess macrophages 
covers both, M1 and M2-like subtypes. Therefore, the increased macrophages in the ASC-treated graft at 8 weeks 
may include more M2 than M1 phenotypes. Although not significantly different from ASC-seeded scaffolds at 4 
weeks, this trend towards higher inflammatory cell densities was also reflected in lymphocytes. As we had found 
lower inflammatory reaction for the pure PLGA/aCaP mesh used as chest wall graft and seeded with ASCs in a 
previous work26, the small increase in the inflammatory reaction found here could be attributed to the reinforce-
ment of the chest wall graft by the pristine PLGA mesh – which is known to evoke local pH drops that in turn 
stimulate an inflammatory response.
There are many reports that show the advantageous impact on angiogenesis and vascularization by ASC ther-
apy or ASC-seeded delivery devices and biomaterials64–67.
As for the hybrid nanocomposite used here, the grafts with stem cells had smaller endothelial cell densi-
ties compared to PLGA/aCaP without cells (Fig. 8). This stands in accordance with previous findings in our 
group26 and can be explained by steric hindrance: The cellular density in grafts with cells was so high that 
neo-vascularization was more challenging compared to scaffolds without cells, exhibiting open pores that were 
easily to access and infiltrate. Still, compared to the gold standard Gore-Tex, our novel ASC-seeded hybrid 
Figure 8. Endothelial cells. Typical CD31 stained histological sections and densities of endothelial cells at two 
time points (A–D) stained positive for CD31 in different zones from skin side (E) and from lung side (F).
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scaffold allowed significantly more vessel ingrowth because Gore-Tex does not allow any vessel to grow into the 
inert material.
A hybrid scaffold made of electrospun PLGA/aCaP and a layer of pristine PLGA is a superior biomaterial 
for chest wall reconstruction compared to PLGA/aCaP without PLGA. The main and important advantage is its 
preserved mechanical stability, even after a two-week cell culture in vitro, allowing an easy application of ASCs 
or other cells in combination with the hybrid material. In vivo, this novel hybrid material successfully closes and 
repairs critical size chest wall defects in mice. The seeding of ASCs onto the hybrid scaffolds leads to an enhanced 
recruitment of hematopoietic cells, supporting the regeneration at the defect site. The technically easy isolation 
of ASCs from fat allows a viable option to seed such scaffolds and use them to close and reconstruct chest wall 
defects, e.g. after tumour resection in clinics which at the same time is the main indication for thoracic wall 
resection. Hence, patients with aggressive tumours would be the group of patients that would benefit from such 
a treatment. Although mild increased inflammatory response, ASC-seeded hybrid scaffold offers everything a 
thoracic surgeon needs to close a chest wall defect – a stable, easy to handle material, which can be adjusted flex-
ibly to the shape of the defect, is adequately vascularized and biodegradable over time, paving its way for future 
clinical application.
References
 1. Tukiainen, E. Chest wall reconstruction after oncological resections. Scand. J. Surg. 102, 9–13 (2013).
 2. Hazel, K. & Weyant, M. J. Chest Wall Resection and Reconstruction: Management of Complications. Thorac. Surg. Clin. 25, 517–521 
(2015).
 3. Yoshiya, K., Koizumi, T., Shinohara, H., Aoki, T. & Koike, T. Chest wall reconstruction after resection of chest wall tumors. Kyobu 
Geka 67, 31–35 (2014).
 4. Lee, S., Jung, Y. & Bae, Y. Immediate chest wall reconstruction using an external oblique myocutaneous flap for large skin defects 
after mastectomy in advanced or recurrent breast cancer patients: A single center experience. J. Surg. Oncol (2017).
 5. Romolo, H., Andinata, B., Aisiyah, D. & Budiluhur, A. Sternal reconstruction for primary sternal tumor in a post-coronary artery 
bypass grafting surgery patient. Sage Open Medical Case Reports 7 (2019).
 6. de Battisti, A., Polton, G., de Vries, M. & Friend, E. Chest wall reconstruction with latissimus dorsi and an autologous thoracolumbar 
fascia graft in a dog. 56, 218–222, (2015).
 7. Sandler, G. & Hayes-Jordan, A. Chest wall reconstruction after tumor resection. Semin. Pediatr. Surg. 27, 200–206 (2018).
 8. Zor, M. H. et al. Single-stage repair of the anterior chest wall following sternal destruction complicated by mediastinitis. Surg. Today 
44, 1476–1482 (2014).
 9. Sakai, M., Yamaoka, M., Goto, Y. & Sato, Y. Subscapularis muscle flap for reconstruction of posterior chest wall skeletal defect. Int. J. 
Surg. Case Rep. 10, 198–200 (2015).
 10. Robinson, L. A. & Grubbs, D. M. Using “Rebar” to Stabilize Rigid Chest Wall Reconstruction. Thorac. Cardiovasc. Surg. 64, 266–269 
(2016).
 11. Hamaji, M. et al. A synthetic bioabsorbable sheet may prevent postoperative intrapleural adhesions following thoracotomy: a canine 
model. Interact. Cardiovasc. Thorac. Surg. 19, 914–920 (2014).
 12. Zhang, R. et al. Biosynthetic Nanostructured Cellulose Patch for Chest Wall Reconstruction: Five-Month Follow-up in a Porcine 
Model. J. Invest. Surg. 30, 297–302 (2017).
 13. Lindenmann, J. Tissue engineering in thoracic surgery. European Surgery-Acta Chirurgica. Austriaca 45, 161–168 (2013).
 14. Bryant, J. R., Eid, R. D. O., Spann, J. C. & Miller, A. S. Chest Wall Reconstruction with Creation of Neoribs Using Mesenchymal Cell 
Bone Allograft and Porcine Small Intestinal Submucosa. Plast. Reconstr. Surg. 126, 148e–149e (2010).
 15. Miller, D. L. et al. Chest Wall Reconstruction Using Biomaterials. The Annals of Thoracic Surgery 95, 1050–1056 (2013).
 16. Aubá, C. et al. Perforator Flaps Covering Alloplastic Materials in Full-Thickness Chest Wall Defects Reconstruction: A Safe Option? 
Plastic and Reconstructive Surgery Global Open 5, e1289 (2017).
 17. Murphy, F. & Corbally, M. T. The novel use of small intestinal submucosal matrix for chest wall reconstruction following Ewing’s 
tumour resection. Pediatr. Surg. Int. 23, 353–356 (2007).
 18. Mestak, O. et al. Mesenchymal Stem Cells Seeded on Cross-Linked and Noncross-Linked Acellular Porcine Dermal Scaffolds for 
Long-Term Full-Thickness Hernia Repair in a Small Animal Model. Artif. Organs 38, 572–579 (2014).
 19. Khalpey, Z. et al. First in Man: Sternal Reconstruction with Autologous Stem Cells. ASAIO J. 61, E31–E32 (2015).
 20. Zhang, Y. Z. et al. Experimental study of ASCs combined with POC-PLA patch for the reconstruction of full-thickness chest wall 
defects. PLoS One 12 (2017).
 21. Xuan, Y. et al. A specific groove design for individualized healing in a canine partial sternal defect model by a polycaprolactone/
hydroxyapatite scaffold coated with bone marrow stromal cells. Journal of Biomedical Materials Research Part A 102, 3401–3408 
(2014).
 22. Xie, H.-Q. et al. Tissue-engineered ribs for chest wall reconstruction: a case with 12-year follow-up. Regen. Med. 9, 431–436 (2014).
 23. Sanna, S. et al. Materials and techniques in chest wall reconstruction: a review. J Vis Surg 3, 95–95 (2017).
 24. Follin, B. et al. Human adipose-derived stromal cells in a clinically applicable injectable alginate hydrogel: Phenotypic and 
immunomodulatory evaluation. Cytotherapy 17, 1104–1118 (2015).
 25. Tour, G., Wendel, M. & Tcacencu, I. Bone marrow stromal cells enhance the osteogenic properties of hydroxyapatite scaffolds by 
modulating the foreign body reaction. J. Tissue Eng. Regen. Med. 8, 841–849 (2014).
 26. Buschmann, J. et al. Effects of seeding adipose-derived stem cells on electrospun nanocomposite used as chest wall graft in a murine 
model. Injury 48, 2080–2088 (2017).
 27. Jungraithmayr, W. et al. Bioactive nanocomposite for chest-wall replacement: Cellular response in a murine model. J. Biomater. Appl. 
29, 36–45 (2013).
 28. Buschmann, J. et al. Yield and proliferation rate of adipose-derived stem cells as a function of age, BMI and harvest site: Increasing 
the yield by using adherent and supernatant fractions? Cytotherapy 15, 1098–1105 (2013).
 29. Buschmann, J. et al. Tissue engineered bone grafts based on biomimetic nanocomposite PLGA/amorphous calcium phosphate 
scaffold and human adipose-derived stem cells. Injury 43, 1689–1697 (2012).
 30. Hess, S. C. et al. Gene expression in human adipose-derived stem cells: comparison of 2D films, 3D electrospun meshes or co-
cultured scaffolds with two-way paracrine effects. Eur. cells mat 34, 232–248 (2017).
 31. Loher, S. et al. Fluoro-apatite and calcium phosphate nanoparticles by flame synthesis. Chem. Mater. 17, 36–42 (2005).
 32. Zuk, P. A. et al. Multilineage cells from human adipose tissue: Implications for cell-based therapies. Tissue Eng. 7, 211–228 (2001).
 33. Buschmann, J. et al. Cellular response of healing tissue to DegraPol tube implantation in rabbit Achilles tendon rupture repair: an in 
vivo histomorphometric study. J. Tissue Eng. Regen. Med. 7, 413–420 (2013).
 34. Gong, L. et al. Effects of human adipose-derived stem cells on the viability of rabbit random pattern flaps. Cytotherapy 16, 496–507 
(2014).
1 1Scientific RepoRts |         (2019) 9:10910  | https://doi.org/10.1038/s41598-019-47441-9
www.nature.com/scientificreportswww.nature.com/scientificreports/
 35. Dorati, R. et al. Long-Term Effect of Gamma Irradiation on the Functional Properties and Cytocompatibility of Multiblock Co-
Polymer Films. Journal of Biomaterials Science-Polymer Edition 23, 2223–2240 (2012).
 36. Oh, B. et al. Split Tolerance in a Murine Model of Heterotopic En Bloc Chest Wall. Transplantation. Plastic and Reconstructive 
Surgery Global Open 5, e1595 (2017).
 37. Lin, S. R., Kastenberg, Z. J., Bruzoni, M., Albanese, C. T. & Dutta, S. Chest wall reconstruction using implantable cross-linked 
porcine dermal collagen matrix (Permacol). J. Pediatr. Surg. 47, 1472–1475 (2012).
 38. Watson, W. L. & James, A. G. Fascia lata grafts for chest wall defects. J. Thorac. Surg. 16, 399–406 (1947).
 39. Bisgard, J. D. & Swenson, S. A. Tumors of the sternum - report of a case with special operative technic. Arch. Surg. 56, 570–585 
(1948).
 40. Campbell, D. A. Reconstruction of the anterior thoracic wall. J. Thorac. Surg. 19, 456–461 (1950).
 41. Abbes, M. & Huss, M. Brest and chest-wall reconstruction by latissimus-dorsi myocutandous flap (238 cases). Breast 4, 33–39 
(1995).
 42. Wu, Y. M., Zhang, G. F., Zhu, Z. Y. & Chai, Y. Chest wall reconstruction after resection using hernia repair piece. J. Thorac. Dis. 8 
(2016).
 43. Rocco, G. et al. The Use of Biomaterials for Chest Wall Reconstruction 30 Years After Radical Surgery and Radiation. The Annals of 
Thoracic Surgery 94, e109–e110 (2012).
 44. Schulz-Drost, S. et al. Elastic Stable Chest Repair as a Means of Stabilizing the Anterior Chest Wall in Recurrent Pectus Excavatum 
with Sternocostal Pseudarthrosis: An Innovative Fixation Device. Thorac. Cardiovasc. Surg. 63, 419–426 (2015).
 45. Wen, X. et al. Chest-wall reconstruction with a customized titanium-alloy prosthesis fabricated by 3D printing and rapid 
prototyping. J. Cardiothorac. Surg. 13, 4–11 (2018).
 46. Kurenov, S. N., Ionita, C., Sammons, D. & Demmy, T. L. Three-dimensional printing to facilitate anatomic study, device development, 
simulation, and planning in thoracic surgery. The Journal of Thoracic and Cardiovascular Surgery 149, 973–979.e971 (2015).
 47. Sharaf, B., Sabbagh, M. D., Vijayasekaran, A., Allen, M. & Matsumoto, J. Virtual surgical planning and three-dimensional printing 
in multidisciplinary oncologic chest wall resection and reconstruction: A case report. Int. J. Surg. Case Rep. 47, 52–56 (2018).
 48. Evans, K. K., Mardini, S. & Arnold, P. G. Chest Wall Reconstruction. Semin. Plast. Surg. 25, 3–4 (2011).
 49. Banyard, D. A., Bourgeois, J. M., Widgerow, A. D. & Evans, G. R. D. Regenerative Biomaterials: A Review. Plast. Reconstr. Surg. 135, 
1740–1748 (2015).
 50. Kim, J. J. & Evans, G. R. D. Applications of Biomaterials in Plastic Surgery. Clin. Plast. Surg. 39, 359–376 (2012).
 51. Hench, L. L., Splinter, R. J., Allen, W. C. & Greenlee, T. K. Bonding mechanisms at the interface of ceramic prosthetic materials. J. 
Biomed. Mater. Res. 5, 117–141 (1971).
 52. Miguez-Pacheco, V., Hench, L. L. & Boccaccini, A. R. Bioactive glasses beyond bone and teeth: Emerging applications in contact 
with soft tissues. Acta Biomaterialia 13, 1–15 (2015).
 53. Jones, J. R., Sepulveda, P. & Hench, L. L. Dose-dependent behavior of bioactive glass dissolution. J. Biomed. Mater. Res. 58, 720–726 
(2001).
 54. Schneider, O. D. et al. In vivo and in vitro evaluation of flexible, cottonwool-like nanocomposites as bone substitute material for 
complex defects. Acta Biomaterialia 5, 1775–1784 (2009).
 55. Schneider, O. D. et al. Biocompatibility and bone formation of flexible, cotton wool-like PLGA/calcium phosphate nanocomposites 
in sheep. The Open Orthopaedics Journal 5, 63–71 (2011).
 56. Uccelli, A., Moretta, L. & Pistoia, V. Immunoregulatory function of mesenchymal stem cells. Eur. J. Immunol. 36, 2566–2573 (2006).
 57. Plock, J. A. et al. Adipose- and Bone Marrow-Derived Mesenchymal Stem Cells Prolong Graft Survival in Vascularized Composite 
Allotransplantation. Transplantation 99, 1765–1773 (2015).
 58. Feizpour, A., Boskabady, M. H. & Ghorbani, A. Adipose-Derived Stromal Cell Therapy Affects Lung Inflammation and Tracheal 
Responsiveness in Guinea Pig Model of COPD. PLoS One 9, 1–8 (2014).
 59. Cherubino, M. et al. Human adipose-derived stem cells promote vascularization of collagen-based scaffolds transplanted into nude 
mice. Regen. Med. 11, 261–271 (2016).
 60. Cho, K.-S. et al. Prostaglandin E2 and Transforming Growth Factor-beta Play a Critical Role in Suppression of Allergic Airway 
Inflammation by Adipose-Derived Stem Cells. PLoS One 10, 1–16 (2015).
 61. Shang, Q. et al. Delivery of Adipose-Derived Stem Cells Attenuates Adipose Tissue Inflammation and Insulin Resistance in Obese 
Mice Through Remodeling Macrophage Phenotypes. Stem Cells and Development 24, 2052–2064 (2015).
 62. Manning, C. N. et al. Adipose-derived mesenchymal stromal cells modulate tendon fibroblast responses to macrophage-induced 
inflammation in vitro. Stem Cell. Res. Ther. 6, 1–14 (2015).
 63. Mert, T. et al. Anti-inflammatory and Anti-nociceptive Actions of Systemically or Locally Treated Adipose-Derived Mesenchymal 
Stem Cells in Experimental Inflammatory Model. Inflammation 38, 1302–1310 (2015).
 64. Wang, K. et al. The paracrine effects of adipose-derived stem cells on neovascularization and biocompatibility of a 
macroencapsulation device. Acta Biomaterialia 15, 65–76 (2015).
 65. Eke, G., Mangir, N., Hasirci, N., MacNeil, S. & Hasirci, V. Development of a UV crosslinked biodegradable hydrogel containing 
adipose derived stem cells to promote vascularization for skin wounds and tissue engineering. Biomaterials 129, 188–198 (2017).
 66. Hirsch, T. et al. Implant for autologous soft tissue reconstruction using an adipose-derived stem cell-colonized alginate scaffold. J. 
Plast. Reconstr. Aesthet. Surg. 71, 101–111 (2018).
 67. Wu, Y.-Y. et al. Experimental Study on Effects of Adipose-Derived Stem Cell–Seeded Silk Fibroin Chitosan Film on Wound Healing 
of a Diabetic Rat Model. Ann. Plast. Surg. 80, 572–580 (2018).
Acknowledgements
We thank Ines Kleiber-Schaaf and Andrea Garcete-Bärtschi for histological and immunohistochemical staining.
Author Contributions
J.B. and W.J. designed experiments, S.H. fabricated hybrid nanocomposite, Y.Y., S.H., C.O. and G.M.B. performed 
experiments, J.B., K.S., G.M.B. and W.J. analyzed data, S.H. made Figure 1, J.B. made Figures 2, 3, 5 and SI 1, 
G.M.B. made Figure 5, K.S. made Figures 4, 5, 7 and 8, J.B., Y.Y., K.S., W.J.S., W.W. and W.J. wrote, revised and 
edited manuscript, J.B., W.J.S. and W.J. coordinated and consulted the whole project.
Additional Information
Supplementary information accompanies this paper at https://doi.org/10.1038/s41598-019-47441-9.
Competing Interests: The authors declare no competing interests.
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and 
institutional affiliations.
1 2Scientific RepoRts |         (2019) 9:10910  | https://doi.org/10.1038/s41598-019-47441-9
www.nature.com/scientificreportswww.nature.com/scientificreports/
Open Access This article is licensed under a Creative Commons Attribution 4.0 International 
License, which permits use, sharing, adaptation, distribution and reproduction in any medium or 
format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Cre-
ative Commons license, and indicate if changes were made. The images or other third party material in this 
article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the 
material. If material is not included in the article’s Creative Commons license and your intended use is not per-
mitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the 
copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
 
© The Author(s) 2019
